As surveillance data from sub-Saharan Africa are few, three representative populations of Streptococcus pneumoniae isolates were examined in Kenya for serotype distribution and Etest minimum inhibitory concentrations (MICs) of benzylpenicillin: (1) 75 lung aspirate or blood culture isolates from 301 consecutive adult patients with pneumonia, (2) 112 invasive isolates from continuous pediatric inpatient surveillance over 4 years, and (3) 97 nasopharyngeal isolates from systematically selected sick children. The proportions with benzylpenicillin MICs of §0.1 mg/mL were 0.27, 0.29, and 0.47, respectively. Vaccine-related serotypes accounted for 96% of invasive isolates from children and 90% of those from human immunodeficiency virus (HIV) -seropositive adults. Serotype 1 accounted for 44% of pneumococci from HIV-seronegative patients but only 5% of those from HIVseropositive patients (P Å .0002). Of serotype 1 isolates, 98% were susceptible to benzylpenicillin, but serogroups 13, 14, 19, and 23 were strongly associated with an MIC of §0.1 mg/mL.
The rising prevalence of resistance to penicillin in Streptoweight to the formulation of new multivalent conjugate vaccines and to inform global recommendations on the empirical coccus pneumoniae isolates and the advent of conjugate pneumococcal vaccines have created an urgent need for comprehentreatment of pneumococcal disease syndromes [16, 17] . sive geographic surveillance. In global terms, however, the volume of data available is inversely related to the local incidence of invasive pneumococcal disease. For example, the literMethods ature on serotype distributions and prevalence of resistance published in 1996 mentions 5,000 invasive isolates of S. pneuLaboratory setting and study populations. All assays were moniae reported from the United States alone [1 -10] but õ500 performed at the Kenya Medical Research Institute (KEMRI) from the whole African continent [11 -15] . Unfortunately, the coastal research unit at Kilifi District Hospital (KDH), 60 km inadequacy of incidence data from developing countries prefrom Mombasa on the Indian Ocean coast. Isolates of S. pneucludes a precise comparison with data from the developed moniae were defined as gram-positive, optochin-susceptible, aworld.
hemolytic colonies that demonstrated either a positive Quellung However, some inferences can be drawn by comparison of reaction with specific anticapsular pneumococcal antisera or the annual incidence of invasive pneumococcal disease in Calielse bile solubility. They were obtained from three different fornian children £5 years old (72 per 100,000 [9] ) with the sources. minimum incidence estimates for children õ5 years old in a Population A isolates were obtained from blood and lung rural district in The Gambia (242 per 100,000 [14] ). Microbioaspirate cultures of 301 consecutive adult patients with acute logical information from well characterized populations in the community-acquired pneumonia admitted to either KDH or developing world is essential to give adequate geographic Coast Provincial General Hospital (Mombasa) between March 1994 and May 1996. Population B isolates were derived from clinical investigations of children aged £12 years who were admitted to KDH between 1992 and 1996. Population C iso-Serotyping. The serogroups of S. pneumoniae isolates were groups were specified with a series of dummy variables, and serotype 1 was used as the baseline comparison. Serogroups determined by Quellung reaction with 12 pools of rabbit pneumococcal antisera in the Danish checkerboard typing system, with less than five isolates were collapsed into one stratum.
Statistical calculations were performed with use of STATA together with pools G and I [18] . The laboratory of the Oxford Vaccine Group (University of Oxford, UK) verified a sample (Stata, College Station, TX); P values assume two-tailed distributions, and 95% confidence intervals are reported. of the serotyping results. A small number of pneumococci were typed by latex agglutination during the process of isolation. If broth culture of a normally sterile body fluid became turbid Results but did not produce viable subcultures on solid media, the broth was centrifuged and the supernatant tested for pneumococcal Serotyping. From 75 adult patients (mean age, 32 years) with pneumonia, there were 73 frozen isolates of S. pneumoniae, of antigens [19] with use of a monospecific latex agglutination assay against the 10 most common serogroups cultured in Kilifi which one could not be retrieved for serotyping; three further serotypes were derived by latex agglutination of failed broth and Mombasa (serogroups 1, 4, 5, 6, 7, 9, 12, 14, 19, and 22 Analyses. Serotype results and the Etest readings from all ifi to the pool level only, the final serotype designation was consistent with the original pool for 20; 1 remaining nasophafive observers were double-entered and verified with use of Epi Info, version 6 (Centers for Disease Control and Prevention, ryngeal isolate was recultured as an optochin-resistant, bileinsoluble contaminant and is excluded from the results below. Atlanta). Readings were specified to the next highest mark on the Etest strip, rather than the next two-fold dilution. For each
The serogroups are summarized in figure 1 . The collections of invasive isolates are dominated by serotypes 1 and 14, and isolate the MIC was defined as the median of the 3 -5 observers' readings. Median MICs were plotted as frequency distributhe nasopharyngeal isolates by serogroups 6 and 19. Fewer serotypes were represented in the collections from invasive tions in the original Etest scale and were also categorized as follows. Penicillin-nonsusceptible pneumococci (PNSP) were pediatric infections than in those from adult patients with pneumonia. For example, the six commonest serogroups accounted distinguished from penicillin-susceptible pneumococci (PSP) if the median MIC was §0.1 mg/mL; penicillin-resistant pneufor 80% of all invasive childhood infections but only 65% of adult infections (P Å .033). For children, several serotypes that mococci (PRP) were defined by a median MIC of §2.0 mg/mL [1] . For this categorization, Etest readings between conwere common in the invasive-isolate collections were uncommon (serotypes 4 and 5) or absent (serotype 1 and serogroup ventional twofold dilutions were rounded up. Associations between MIC and study population were tested by means of the 18) in the collection of nasopharyngeal isolates. HIV antibody tests were conducted on all 75 adult patients, x 2 test with Yates's continuity correction.
To evaluate the association between serotype and MIC, a and 39 (52%) were positive. Although the two groups were of roughly equal size, the HIV-positive patients were infected logistic regression model was developed with PNSP/PSP as the dependent variable and age, site of isolation, study populawith a total of 20 different serotypes (table 1) , whereas the infections in HIV-seronegative patients were confined to only tion, and serogroup as explanatory variables. Individual sero-/ 9c5c$$de04
11-11-98 00:00:46 cidal UC: CID / 9c5c$$de04 11-11-98 00:00:46 cidal UC: CID accountable entirely by the serogroup distribution and was dropped from the final model. Population of origin was considered a priori a potential confounder of the serotype-resistance associations and was retained in the final model, although it nine serotypes. Serotype 1 pneumococci accounted for 44.4% of all infections in HIV-seronegative patients but only 5.1%
did not significantly improve the model fit estimated by the likelihood ratio test. of those in HIV-seropositive patients (P Å .0002).
MICs. MICs were measured by Etest for 269 isolates: 71 of Table 2 shows the adjusted odds ratios from the final model. The odds of finding PNSP are more than 600 times greater for the isolates from adults, 108 of the isolates from children with invasive disease, and 90 of the isolates from nasopharyngeal serotype 14 than for serotype 1. Other serogroups strongly associated with an MIC of §0.1 mg/mL are 13, 19, and 23. samples from children. Among the nasopharyngeal isolates, 22 (24%) were recovered from children whose discharge diagnosis Significant associations of lesser magnitude are seen for serogroups 6, 9, and 11. was acute lower respiratory tract infection, and in association with 12 isolates (13%) the mother of the sampled child gave
The proportions of all isolates that were of vaccine-related serotypes, including cross-reacting types [20] , were 96% (CI, a history of antibiotic use in the preceding week.
Two hundred and sixty-five Etests were read by all five 92% -99%) for children with invasive disease and 92% (CI, 85% -98%) for adults with acute pneumonia; for HIV-seroposiobservers. Of 1,325 comparisons between the median MIC and individual observer readings, all but three were within one twotive adults the proportion was 90% (CI, 80% -99%). Data derived from latex agglutination of broth cultures were excluded fold dilution. Median MICs for the control isolates, assayed on nine separate occasions, fell within the ranges of 0.004 -from these calculations, as there was no possibility in this assay of detecting nonvaccine serotypes. A conjugate vaccine 0.012 mg/mL for ATCC 6305 and 0.19 -0.50 mg/mL for the local strain. Median MICs for all 269 test isolates in each of containing, for example, serotypes 1, 3, 4, 5, 6A, 6B, 14, 18C, 19F, and 23F would have cross-reactive coverage of 90% (CI, the three populations are shown in figure 2. The histograms illustrate approximately bimodal distributions representing two 85% -96%) for the isolates identified from children with invasive disease. populations of isolates, one of PSP and the other of PNSP; amongst the PNSP, no PRP were identified.
Of the isolates from adults, 27% (CI, 17% -37%) were Discussion PNSP. The proportion of isolates from children that were PNSP was significantly higher in the nasopharyngeal population
The Danish checkerboard typing system, with only 14 pools of antisera [18] , enabled us to define the serogroup of 82% of (47%; CI, 36% -57%) than in the invasive population (29%; CI, 20% -37%; P Å .014). Amongst isolates from the nasopharnasopharyngeal isolates, 92% of adult pneumonia isolates, and 95% of invasive pediatric isolates on site in Kenya. The distriynx, the proportions of PNSP did not differ significantly be-/ 9c5c$$de04
11-11-98 00:00:46 cidal UC: CID / 9c5c$$de04 11-11-98 00:00:46 cidal UC: CID butions of the invasive isolates were similar to those in collecpercentage (15%) of invasive infections with organisms of serotype 14 is unusual in tropical Africa [15, 22, 24] [16, 20, 27, 28] . Serotype 1 is uncommon and serotype 5 is now rare in the developed world [29] , but in Coastal Kenya
The data from invasive isolates confirm the local applicability of the 23-valent capsular polysaccharide vaccine in both they comprised 24% and 11% of invasive isolates, respectively. Organisms of serogroups 6, 19, and 23 were more common in adults and children [20] and demonstrate that excellent coverage (90%) could be achieved in children with use of the smaller children than in adults in Kenya but still accounted for only 26% of invasive disease episodes in children, compared with number of antigens that are currently contemplated for a nonavalent protein-conjugate vaccine. 36% -43% in American studies [16, 28] .
In two respects, however, the serotype distribution appears Given the large number of pneumococcal serotypes, detecting an association between HIV and serotype distribution similar to the American/European pattern. First, serotype 2 organisms were not observed in this study, although they have requires the accumulation of a significant number of observations. Several small studies failed to detect any association been an invariable feature of previous African collections, comprising 2% -7% of all isolates [21, 22, 24] . Second, the large [32 -34] , and a larger study of 191 blood culture isolates from / 9c5c$$de04 11-11-98 00:00:46 cidal UC: CID [46, 47] . adults at Denver General Hospital also noted no specific association [35] . Serotypes of isolates from a mixed seropositive For six individual serotypes sufficient data were available to examine the serotype-specific distribution of MICs. Three population of 38 adults and children at Yale -New Haven Hospital differed significantly from those recovered from 111 seroserotypes, found only rarely in nasopharyngeal samples (1, 5, and 14), were restricted in the distribution of their MICs; two negative patients [2] ; serotype 9V, in particular, was associated with the HIV-positive group (26% vs. 8%; P õ .01).
PNSP of serotype 5 were the only exception. On the other hand, three serotypes that were commonly found in both nasoIn a study of 359 blood culture isolates from South African adults [31], serotype 1 comprised 39% of the isolates from pharyngeal and invasive isolates (6, 19 , and 23) illustrated a wide diversity of MICs. These observations are consistent with HIV-positive patients but only 20% of those from HIV-negative patients (P õ .002). Organisms of serogroups 6, 14, 19, and 23 the hypothesis that opportunities for acquiring, through recombination, genes conferring different levels of resistance are were, collectively, more common in HIV-seropositive persons (48% vs. 29%; P õ .001). In Kenya the serotype distribution increased in pneumococci of serotypes that are better adapted to colonizing the nasopharynx [48, 49] . of HIV-negative adults is dominated even more strongly by serotype 1, and its depletion in HIV-seropositive persons is
The associations between serotype and PNSP reported here are of significant magnitude. Serotype 14 isolates are more even greater. It is replaced not only by the pediatric serogroups but by a wide dispersion of types, suggesting that amongst likely to be PNSP than are serotype 1 isolates, by a factor of ú600, and serogroups 13, 19, and 23 are also associated with HIV-positive patients exposure to an invasive serotype is less important and that almost any serotype can cause disease in an MIC of §0.1 mg/mL, with an odds ratio of ú40. However, the clinical utility of this information is best estimated by conthe absence of adequate immunity [33] .
Several studies of S. pneumoniae have demonstrated that sidering the predictive value of each serotype for resistance category. For example, a serotyping result with a predictive Etests can reliably reproduce the MIC of benzylpenicillin obtained by the standard broth-dilution assay [36 -38] , and we value for PNSP of §0.50 may prompt a change in therapy for meningitis before the results of susceptibility testing are found that novice observers can read Etest results with minimal interobserver variation. Our study was confined to benzylpeniavailable, and a result with a predictive value for PSP of §0.90 would be clinically reassuring for a patient already receiving cillin because it is the first-line (and often the only) form of inpatient therapy available for the majority of pneumococcal benzylpenicillin. With use of these criteria, serotyping results would be of clinical value only for serotypes 1 and 4, associated disease syndromes in tropical Africa.
Although nearly one-third of invasive isolates in Coastal with PSP, and for serotype 14, associated with PNSP. Serotyping is not a useful substitute for susceptibility testing in this Kenya were PNSP, this is much lower than the levels of 44% -59% reported for invasive isolates in Spain and Korea [39, population.
In three representative populations of S. pneumoniae isolates 40]. Furthermore, consistent with other studies in East Africa, no PRP were identified in Coastal Kenya [15, 21, 41] . Pneumofrom children and adults on the Coast of Kenya, we have / 9c5c$$de04 11-11-98 00:00:46 cidal UC: CID
